{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:10:51Z","timestamp":1778245851318,"version":"3.51.4"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopha.2017.11.149","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T02:06:51Z","timestamp":1512526011000},"page":"936-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Procalcitonin: The marker of pediatric bacterial infection"],"prefix":"10.1016","volume":"96","author":[{"given":"Mohammad Yousef","family":"Memar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Varshochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrooz","family":"Shokouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Asgharzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein Samadi","family":"Kafil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2017.11.149_bib0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1473-3099(04)01146-6","article-title":"Procalcitonin as an early marker of infection in neonates and children","volume":"4","author":"van Rossum","year":"2004","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01740811","article-title":"Procalcitonin\u2014a new indicator of the systemic response to severe infections","volume":"25","author":"Karzai","year":"1997","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02113598","article-title":"Procalcitonin, a marker of bacterial infection","volume":"25","author":"Gendrel","year":"1997","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s150100050049","article-title":"Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis","volume":"28","author":"Hedlund","year":"2000","journal-title":"Infection"},{"issue":"8844","key":"10.1016\/j.biopha.2017.11.149_bib0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0030","first-page":"396","article-title":"Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis 1","volume":"86","author":"Muller","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","article-title":"Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis","volume":"7","author":"Tang","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.149_bib0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/cid\/cir408","article-title":"Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review","volume":"53","author":"Agarwal","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0045","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations","volume":"36","author":"Becker","year":"2008","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc3496","article-title":"Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections","volume":"9","author":"Al-Nakeeb","year":"2005","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.149_bib0055","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1210\/jc.2002-021444","article-title":"Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors","volume":"89","author":"Becker","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10156-005-0388-9","article-title":"Multicenter prospective study of procalcitonin as an indicator of sepsis","volume":"11","author":"Aikawa","year":"2005","journal-title":"J. Infect. Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(02)00047-X","article-title":"Procalcitonin as a marker of sepsis","volume":"20","author":"Carrol","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-2143(99)90053-7","article-title":"Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro","volume":"134","author":"Oberhoffer","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2017.11.149_bib0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00003246-200002000-00028","article-title":"Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro","volume":"28","author":"Groothuis","year":"2000","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","article-title":"Pathobiochemistry and clinical use of procalcitonin","volume":"323","author":"Meisner","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2017.11.149_bib0085","first-page":"S57","article-title":"Physiology and genetics of procalcitonin","volume":"49","author":"Maruna","year":"2000","journal-title":"Physiol. Res."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.149_bib0090","first-page":"1593","article-title":"The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia","volume":"19","author":"Miedema","year":"2011","journal-title":"Support. Care Cancer"},{"issue":"Supplement 3","key":"10.1016\/j.biopha.2017.11.149_bib0095","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/591393","article-title":"Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin","volume":"47","author":"Niederman","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2012.05.002","article-title":"Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis","volume":"73","author":"Riedel","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/520222","article-title":"Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-\u03b11-antitrypsin, and lactoferrin compared with clinical variables","volume":"29","author":"Bossink","year":"1999","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1684-1182(10)60035-7","article-title":"Semi-quantitative procalcitonin test for the diagnosis of bacterial infection: clinical use and experience in Japan","volume":"43","author":"Oshita","year":"2010","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1365-2168.2001.01673.x","article-title":"Procalcitonin strip test in the early detection of severe acute pancreatitis","volume":"88","author":"Kyl\u00e4np\u00e4\u00e4\u2010B\u00e4ck","year":"2001","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.149_bib0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1515\/CCLM.2000.147","article-title":"Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin","volume":"38","author":"Meisner","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0125","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.PCC.0000161289.22464.C3","article-title":"Scope and epidemiology of pediatric sepsis","volume":"6","author":"Watson","year":"2005","journal-title":"Pediatr. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s001340000709","article-title":"Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children","volume":"27","author":"Enguix","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.biopha.2017.11.149_bib0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.biopha.2017.07.011","article-title":"Aptamer-assisted novel technologies for detecting bacterial pathogens","volume":"93","author":"Alizadeh","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.149_bib0140","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.inf.0000091360.11784.21","article-title":"Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker","volume":"22","author":"Lopez","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cyto.2013.02.030","article-title":"The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia","volume":"62","author":"Urbonas","year":"2013","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/514576","article-title":"Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates","volume":"26","author":"Chiesa","year":"1998","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.149_bib0155","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3476(96)70374-8","article-title":"Procalcitonin as a marker for the early diagnosis of neonatal infection","volume":"128","author":"Gendrel","year":"1996","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1651-2227.1997.tb08870.x","article-title":"Procalcitonin and C\u2010reactive protein levels in neonatal infections","volume":"86","author":"Monneret","year":"1997","journal-title":"Acta Paediatr."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.149_bib0165","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00006454-199908000-00003","article-title":"Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants","volume":"18","author":"Franz","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.berh.2011.02.001","article-title":"Septic arthritis","volume":"25","author":"Garc\u00eda-Arias","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.149_bib0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.pec.0000190226.12610.24","article-title":"Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis","volume":"21","author":"Butbul-Aviel","year":"2005","journal-title":"Pediatr. Emerg. Care"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1824-7288-35-33","article-title":"Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial","volume":"35","author":"Faesch","year":"2009","journal-title":"Ital. J. Pediatr."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(09)70306-8","article-title":"Acute bacterial meningitis in infants and children","volume":"10","author":"Kim","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/11593340-000000000-00000","article-title":"Acute bacterial meningitis in infants and children","volume":"13","author":"Agrawal","year":"2011","journal-title":"Pediatr. Drugs"},{"issue":"11","key":"10.1016\/j.biopha.2017.11.149_bib0195","doi-asserted-by":"crossref","first-page":"e50341","DOI":"10.1371\/journal.pone.0050341","article-title":"Performance of thirteen clinical rules to distinguish bacterial and presumed viral meningitis in Vietnamese children","volume":"7","author":"Huy","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jcla.21746","article-title":"Can procalcitonin in cerebrospinal fluid be a diagnostic tool for meningitis?","volume":"29","author":"Konstantinidis","year":"2015","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpeds.2006.02.034","article-title":"Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis","volume":"149","author":"Dubos","year":"2006","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.149_bib0210","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1371\/journal.pone.0000674","article-title":"Aseptic meningitis in children: analysis of 506 cases","volume":"2","author":"Michos","year":"2007","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0215","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1097\/00003246-200006000-00024","article-title":"Serum procalcitonin levels in bacterial and abacterial meningitis","volume":"28","author":"Schwarz","year":"2000","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.149_bib0220","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpedi.162.12.1157","article-title":"Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study","volume":"162","author":"Dubos","year":"2008","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.149_bib0225","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0009922815606414","article-title":"Procalcitonin as a serum biomarker for differentiation of bacterial meningitis from viral meningitis in children evidence from a meta-analysis","volume":"55","author":"Henry","year":"2016","journal-title":"Clin. Pediatr. (Phila)"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00365540600951283","article-title":"Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood","volume":"39","author":"Don","year":"2007","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.biopha.2017.11.149_bib0235","series-title":"Seminars in Pediatric Infectious Diseases","first-page":"191","article-title":"Bacterial pneumonia in children","author":"Adler-Shohet","year":"1998"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.149_bib0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/thorax.57.5.438","article-title":"Differentiation of bacterial and viral pneumonia in children","volume":"57","author":"Virkki","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.biopha.2017.11.149_bib0245","first-page":"163","article-title":"Childhood community-acquired pneumonia","author":"Ruuskanen","year":"1999","journal-title":"Semin. Respir. Infect."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.149_bib0250","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1034\/j.1600-0463.2003.1111005.x","article-title":"Serologically indicated pneumococcal pneumonia in children: a population\u2010based study in primary care settings","volume":"111","author":"Heiskanen-kosma","year":"2003","journal-title":"Apmis"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.149_bib0255","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/adc.84.4.332","article-title":"Procalcitonin in children admitted to hospital with community acquired pneumonia","volume":"84","author":"Moulin","year":"2001","journal-title":"Arch. Dis. Child."},{"issue":"7","key":"10.1016\/j.biopha.2017.11.149_bib0260","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006454-200007000-00003","article-title":"Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children","volume":"19","author":"Toikka","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.149_bib0265","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/INF.0b013e31829ba62a","article-title":"Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children","volume":"32","author":"Galetto-Lacour","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0270","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12013-015-0631-7","article-title":"Significance of serum procalcitonin levels in differential diagnosis of pediatric pneumonia","volume":"73","author":"Zhu","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.biopha.2017.11.149_bib0275","first-page":"2483","article-title":"Urinary tract infection in children","volume":"72","author":"Alper","year":"2005","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.biopha.2017.11.149_bib0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1874285801509010014","article-title":"Spread of enterococcal surface protein in antibiotic resistant Entero-coccus Faecium and enterococcus Faecalis isolates from urinary tract infections","volume":"9","author":"Kafil","year":"2015","journal-title":"Open Microbiol. J."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.104.1.79","article-title":"Oral versus initial intravenous therapy for urinary tract infections in young febrile children","volume":"104","author":"Hoberman","year":"1999","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3476(94)70248-9","article-title":"Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis","volume":"124","author":"Benador","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.biopha.2017.11.149_bib0295","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/397618","article-title":"Procalcitonin: a key marker in children with urinary tract infection","volume":"2011","author":"Leroy","year":"2011","journal-title":"Adv. Urol."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0300","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-001-0790-1","article-title":"Procalcitonin as a marker of acute pyelonephritis in infants and children","volume":"17","author":"Smolkin","year":"2002","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0305","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1542\/peds.114.2.e249","article-title":"Procalcitonin: a marker of severity of acute pyelonephritis among children","volume":"114","author":"Pecile","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0310","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1442-200X.2009.002917.x","article-title":"Usefulness of procalcitonin rapid test for the diagnosis of acute pyelonephritis in children in the emergency department","volume":"52","author":"Nikfar","year":"2010","journal-title":"Pediatr. Int."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0315","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004310000681","article-title":"Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs","volume":"160","author":"Lacour","year":"2001","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.149_bib0320","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.annemergmed.2012.05.027","article-title":"Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis","volume":"60","author":"Yo","year":"2012","journal-title":"Ann. Emerg. Med."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.149_bib0325","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1442-200x.2004.01947.x","article-title":"Non\u2010specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?","volume":"46","author":"Korppi","year":"2004","journal-title":"Pediatr. Int."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.149_bib0330","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00134-009-1637-7","article-title":"Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children","volume":"35","author":"Groselj-Grenc","year":"2009","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.149_bib0335","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1542\/peds.70.5.802","article-title":"Observation scales to identify serious illness in febrile children","volume":"70","author":"McCarthy","year":"1982","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.biopha.2017.11.149_bib0340","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/INF.0b013e31806215e3","article-title":"Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department","volume":"26","author":"Andreola","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0345","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jinf.2010.03.016","article-title":"The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever","volume":"60","author":"Limper","year":"2010","journal-title":"J. Infect."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0350","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s150100070014","article-title":"Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?","volume":"28","author":"De Bont","year":"2000","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0355","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10096-006-0143-x","article-title":"Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer","volume":"25","author":"Kitanovski","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.biopha.2017.11.149_bib0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.micpath.2017.09.028","article-title":"The pathogenesis of Staphylococcus aureus in autoimmune diseases","volume":"111","author":"Seyyed Mousavi","year":"2017","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.149_bib0365","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/clinids\/18.4.589","article-title":"C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia","volume":"18","author":"Santolaya","year":"1994","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.149_bib0370","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/08880010903044797","article-title":"Procalcitonin and C-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer","volume":"26","author":"Martinez-Albarran","year":"2009","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/PEC.0b013e3181c399df","article-title":"Procalcitonin as a marker of severe bacterial infection in children in the emergency department","volume":"26","author":"Deis","year":"2010","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.biopha.2017.11.149_bib0380","first-page":"1","article-title":"Immunologic biomarkers for diagnostic of early-onset neonatal sepsis","volume":"31","author":"Memar","year":"2017","journal-title":"J. Matern Fetal Neonatal Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0385","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.burns.2011.08.021","article-title":"PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment","volume":"38","author":"Lavrentieva","year":"2012","journal-title":"Burns"},{"issue":"11","key":"10.1016\/j.biopha.2017.11.149_bib0390","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/CCM.0b013e3181f17bf9","article-title":"Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Kopterides","year":"2010","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0395","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOP.0000000000000092","article-title":"Use of procalcitonin for the prediction and treatment of acute bacterial infection in children","volume":"26","author":"Pierce","year":"2014","journal-title":"Curr. Opin. Pediatr."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0400","doi-asserted-by":"crossref","first-page":"r072","DOI":"10.1007\/s004240000011","article-title":"Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates","volume":"440","author":"Bona\u010d","year":"2000","journal-title":"Pfl\u00fcg. Archiv"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0405","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1373\/49.1.60","article-title":"C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection","volume":"49","author":"Chiesa","year":"2003","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"Schuetz","year":"2011","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-8-38","article-title":"Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria","volume":"8","author":"Charles","year":"2008","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0420","first-page":"117","article-title":"Procalcitonin as a marker of neonatal sepsis","volume":"19","author":"Zahedpasha","year":"2009","journal-title":"Iran J. Peditr."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.149_bib0425","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/jp.2008.207","article-title":"Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants","volume":"29","author":"Cetinkaya","year":"2009","journal-title":"J. Perinatol."},{"issue":"10","key":"10.1016\/j.biopha.2017.11.149_bib0430","first-page":"851","article-title":"Serum procalcitonin as an early marker of neonatal sepsis","volume":"94","author":"Ballot","year":"2004","journal-title":"S. Afr. Med. J."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.149_bib0435","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3109\/00365541003796775","article-title":"Procalcitonin is useful in identifying bacteraemia among children with pneumonia","volume":"42","author":"Nascimento-Carvalho","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0440","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clinbiochem.2015.09.008","article-title":"Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children","volume":"49","author":"Agnello","year":"2016","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.149_bib0445","doi-asserted-by":"crossref","first-page":"e36927","DOI":"10.1371\/journal.pone.0036927","article-title":"Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia","volume":"7","author":"Cohen","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.149_bib0450","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000241296","article-title":"Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial","volume":"97","author":"Stocker","year":"2009","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.149_bib0455","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(84)80839-X","article-title":"The complete sequence of human preprocalcitonin","volume":"167","author":"Le Moullec","year":"1984","journal-title":"FEBS Lett."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217360298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217360298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:21:46Z","timestamp":1778242906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217360298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":91,"alternative-id":["S0753332217360298"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.149","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procalcitonin: The marker of pediatric bacterial infection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}